hydrochlorothiazide has been researched along with Genetic Diseases, X-Chromosome Linked in 3 studies
Hydrochlorothiazide: A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism.
hydrochlorothiazide : A benzothiadiazine that is 3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted by a chloro group at position 6 and a sulfonamide at 7. It is diuretic used for the treatment of hypertension and congestive heart failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report a case of congenital nephrogenic diabetes insipidus that was complicated by paradoxical water intoxication secondary to liberal water intake and the initiation of hydrochlorothiazide and indomethacin combination therapy." | 3.75 | Nephrogenic diabetes insipidus: treat with caution. ( Boussemart, T; Champion, G; Martin-Coignard, D; Nsota, J, 2009) |
| " In this report, no significant correlations between dosage of hydrochlorothiazide and calciuria and no significant correlations between proteinuria and dosage of enalapril were detected." | 1.38 | The long-term use of enalapril and hydrochlorothiazide in two novel mutations patients with Dent's disease type 1. ( Henriques, Ldos S; Igarashi, T; Koch, VH; Seki, G; Sekine, T; Vaisbich, MH, 2012) |
| "He had been diagnosed clinically with nephrogenic diabetes insipidus and treated by amiloride and hydrochlorothiazide combination without a satisfactory outcome at another center since 1 year of age." | 1.33 | Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus. ( Hoefsloot, L; Kasap, B; Kavukçu, S; Oğün, N; Oztürk, Y; Soylu, A; Türkmen, M, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boussemart, T | 1 |
| Nsota, J | 1 |
| Martin-Coignard, D | 1 |
| Champion, G | 1 |
| Vaisbich, MH | 1 |
| Henriques, Ldos S | 1 |
| Igarashi, T | 1 |
| Sekine, T | 1 |
| Seki, G | 1 |
| Koch, VH | 1 |
| Soylu, A | 1 |
| Kasap, B | 1 |
| Oğün, N | 1 |
| Oztürk, Y | 1 |
| Türkmen, M | 1 |
| Hoefsloot, L | 1 |
| Kavukçu, S | 1 |
3 other studies available for hydrochlorothiazide and Genetic Diseases, X-Chromosome Linked
| Article | Year |
|---|---|
Nephrogenic diabetes insipidus: treat with caution.
Topics: Amiloride; Combined Modality Therapy; Cyclooxygenase Inhibitors; Diabetes Insipidus, Nephrogenic; Di | 2009 |
The long-term use of enalapril and hydrochlorothiazide in two novel mutations patients with Dent's disease type 1.
Topics: Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Enalapril; Genetic Diseases, X-Li | 2012 |
Efficacy of COX-2 inhibitors in a case of congenital nephrogenic diabetes insipidus.
Topics: Amiloride; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Diabetes Insipidus, Nephrogenic; Diuretics | 2005 |